Business Context and Reporting Period
This Form 6-K filing by Prana Biotechnology Limited (ASX Code: PBT) covers the month of August 2013. The registrant is a foreign private issuer based in Australia. The filing serves as a notice under Section 708A(5) of the Corporations Act regarding a share issuance.
Key Financial Metrics
The filing does not provide standard financial statements, revenue, profit, cash flow, or debt metrics. The only financial data disclosed relates to a specific capital raise event:
- Shares Issued: 3,601,550 Ordinary Fully Paid Shares
- Issue Date: August 6, 2013
- Total Proceeds: AUD$1,416,026
- Implied Issue Price: Approximately AUD$0.393 per share
Material Changes
The primary material change is the increase in the company's share capital through the issuance of 3,601,550 new ordinary shares. The filing states these shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act. No other material changes to operations or financial position are detailed in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, or outlook. It confirms that as of the filing date, the company has complied with Chapter 2M of the Corporations Act and Section 674. The company also states there is no "excluded information" required to be disclosed.
Investor Verification Checklist
- Verify the total number of issued shares and the exact proceeds raised (AUD$1,416,026) in the company's latest audited financial statements.
- Confirm the dilution impact of the 3,601,550 new shares on existing shareholders.
- Review the company's cash position to determine how the raised capital is being utilized, as this filing does not specify the use of proceeds.
- Check for any subsequent filings regarding the "excluded information" status mentioned in this notice.